'Heart resilience' biomarker may help predict chemotherapy-induced cardiac damage earlier
Friday, December 21, 2012 - 11:00
in Health & Medicine
Anthracyclines, a class of chemotherapy drugs commonly used to treat breast and childhood cancers are effective, but can cause heart damage that doesn't appear until long after treatment is over. By analyzing cardiac magnetic resonance imaging and heart health biomarkers in breast cancer patients, researchers were able to identify slight changes in heart function that could help identify which cancer patients are more likely to suffer cardiac issues later in life.